Anika Therapeutics, Inc. - ANIK

SEC FilingsOur ANIK Tweets

About Gravity Analytica

Recent News

  • 09.05.2025 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 08.27.2025 - Why Choosing a Non-Xenograft Implant Matters
  • 07.30.2025 - Anika Reports Second Quarter 2025 Financial Results
  • 07.30.2025 - Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
  • 07.16.2025 - Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
  • 07.03.2025 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 06.24.2025 - Regenerative Medicine in Orthopedics: Building Stronger Pathways for Healing

Recent Filings

  • 07.30.2025 - 8-K Current report
  • 07.30.2025 - 8-K Current report
  • 07.30.2025 - EX-99.1 EX-99.1
  • 07.30.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 07.30.2025 - EX-99.1 EX-99.1
  • 06.24.2025 - 8-K Current report
  • 06.24.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.24.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.24.2025 - 4 Statement of changes in beneficial ownership of securities
  • 06.24.2025 - 4 Statement of changes in beneficial ownership of securities